August 2015 Issue Table Of Contents

From The Editor

• Are We Truly Investing To Meet The World’s Unmet Medical Need?

Feature Articles

• How Bayer Relieved My Innovation Neurosis
• Can Nano Bring Us Back From Personalized To Mass Medicine?
• Why Is Takeda Focusing On Vaccines?

The Enterprisers

• ContraVir: Mapping A Circuitous Route To Value

Industry Explorers Blaze On

• How The Journey To Entrepreneurial Biotech Begins  -- David Hale

Capitol Perspectives

• Rx Industry Fighting Off New Salvos To Extract Medicare Savings

Companies To Watch

• Thrasos Therapeutics

Deeper Dive

• Warning: Don’t Let Bio-Euphoria Distract You From Being Disciplined

Outsourcing Insights

• Outsourcing Increasing To CROs And CMOs Known For Quality And Cost-Effectiveness

Inside The Industry

• Building A Narrative: Develop Emotional Connections To Raise Capital
• Alzheimer’s Drug Development: Not An Easy Path To Pursue

Leadership Lessons

• 7 Steps For Boosting Your Influence

Ask The Board

• Ask The Board: What Is The Greatest Insight Gained From Attending The 2015 ISPE/FDA Quality Week?